Free Trial

Thomas Smith - Leerink Partners Analyst Performance

This page shows the methodology used to calculate Thomas Smith's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily.

MarketBeat Analyst Ranking:
Average 12-Month ROI of Buy and Strong Buy Recommendations: ???%

CompanyReport DateReport Date Price12-Month
Price Target
Rating12-Month
Actual Price
12-Month
ROI
Details
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
7/23/2025$65.45$74.00Outperform???%???%
Equillium, Inc. stock logo
EQ
Equillium
3/28/2025$0.49$1.00Market Perform???%???%
Immunic, Inc. stock logo
IMUX
Immunic
10/21/2022$9.20$5.00Market Perform???%???%
DICE Therapeutics, Inc. stock logo
DICE
DICE Therapeutics
10/11/2022$39.91$77.00Outperform???%???%
MoonLake Immunotherapeutics stock logo
MLTX
MoonLake Immunotherapeutics
8/25/2022$9.01$17.00Outperform???%???%
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
7/20/2022$22.89$26.00Market Perform???%???%
Morphic Holding, Inc. stock logo
MORF
Morphic
7/20/2022$24.99$45.00Outperform???%???%
Connect Biopharma Holdings Limited Sponsored ADR stock logo
CNTB
Connect Biopharma
4/1/2022$3.05$22.00Buy???%???%
Landos Biopharma, Inc. stock logo
LABP
Landos Biopharma
11/16/2021$140.10$160.00Market Perform???%???%
Landos Biopharma, Inc. stock logo
LABP
Landos Biopharma
10/7/2021$14.87Buy???%???%
Landos Biopharma, Inc. stock logo
LABP
Landos Biopharma
7/30/2021$109.80$200.00Buy???%???%
Axcella Health Inc. stock logo
AXLA
Axcella Health
7/30/2021$85.00$250.00Buy???%???%
Intercept Pharmaceuticals, Inc. stock logo
ICPT
Intercept Pharmaceuticals
6/30/2020$46.70$50.00Market Perform???%???%
AMAG Pharmaceuticals, Inc. stock logo
AMAG
AMAG Pharmaceuticals
2/28/2018$20.75$24.00Overweight???%???%
AMAG Pharmaceuticals, Inc. stock logo
AMAG
AMAG Pharmaceuticals
11/3/2017$12.80$22.00Overweight???%???%


Return to Analyst Rankings